Literature DB >> 10800721

Preparation of rhenium-188-tin colloid as a radiation synovectomy agent and comparison with rhenium-188-sulfur colloid.

J M Jeong1, Y J Lee, Y J Kim, Y S Chang, D S Lee, J K Chung, Y W Song, M C Lee.   

Abstract

As a generator-produced beta-emitting radionuclide, the importance of 188Re for radionuclide therapy is increasing rapidly. We prepared 188Re-tin colloid and compared its properties with 188Re-sulfur colloid. Labeling efficiencies reached >98% for tin colloid at 2 h and 89-94% for sulfur colloid at 3 h. All the preparations were stable for 72 h in water, serum, and synovial fluid. If labeled at higher temperature, the particle size of tin colloid increased. The residual radioactivity of 188Re-sulfur colloid in disposable polypropylene syringes after injecting mice was high (62.0+/-7.0%) due to its hydrophobic nature, while that of 188Re-tin colloid was low (2.9+/-1.6%). Although both 188Re-tin colloid and 188Re-sulfur colloid might be useful for radionuclide therapy, we conclude that 188Re tin colloid is more advantageous over 188Re sulfur colloid, due to higher labeling efficiency, control of the particle size, and lower residual activity in the injection syringes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10800721     DOI: 10.1016/s0969-8043(99)00131-1

Source DB:  PubMed          Journal:  Appl Radiat Isot        ISSN: 0969-8043            Impact factor:   1.513


  8 in total

1.  99mTc/188Re-labelled lipid nanocapsules as promising radiotracers for imaging and therapy: formulation and biodistribution.

Authors:  Sandrine Ballot; Nicolas Noiret; François Hindré; Benoît Denizot; Etienne Garin; Holisoa Rajerison; Jean-Pierre Benoit
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-02-01       Impact factor: 9.236

2.  Pharmacokinetics of radioimmunotherapeutic agent of direct labeling mAb 188Re-HAb18.

Authors:  Chao Lou; Zhi-Nan Chen; Hui-Jie Bian; Jie Li; Shou-Bo Zhou
Journal:  World J Gastroenterol       Date:  2002-02       Impact factor: 5.742

Review 3.  KSNM60: The History of Radiopharmaceutical Sciences in Korea.

Authors:  Ran Ji Yoo; Yun-Sang Lee; Kyo Chul Lee; Dong Wook Kim; Dong-Yeon Kim; Yearn Seong Choe; Jae Min Jeong
Journal:  Nucl Med Mol Imaging       Date:  2022-04-05

Review 4.  KSNM60 in Non-thyroidal Radionuclide Therapy: Leaping into the Future.

Authors:  Byung Hyun Byun; Myoung Hyoun Kim; Yeon-Hee Han; Hwan-Jeong Jeong
Journal:  Nucl Med Mol Imaging       Date:  2021-08-23

5.  Synthesis of the first radiolabeled 188Re N-heterocyclic carbene complex and initial studies on its potential use in radiopharmaceutical applications.

Authors:  Thomas Wagner; Brian M Zeglis; Sam Groveman; Claudia Hille; Alexander Pöthig; Lynn C Francesconi; Wolfgang A Herrmann; Fritz E Kühn; Thomas Reiner
Journal:  J Labelled Comp Radiopharm       Date:  2014-05-29       Impact factor: 1.921

6.  Physico-chemical characterisation and biological evaluation of 188-Rhenium colloids for radiosynovectomy.

Authors:  Ma Ures; Eduardo Savio; Antonio Malanga; Marcelo Fernández; Andrea Paolino; Javier Gaudiano
Journal:  BMC Nucl Med       Date:  2002-10-14

7.  Radiosynovectomy of Proximal Interphalangeal Joint Synovitis in Rheumatoid Arthritis Treated with Rhenium-188 Labeled Tin-colloid and Imaging with Single-photon Emission Computerized Tomography/Computed Tomography: A First Case Report.

Authors:  Koramadai Karuppusamy Kamaleshwaran; Venkataraman Rajamani; Boopathi Krishnan; Madhav Mallia; Radhakrishnan Kalarikal; Vyshakh Mohanan; Ajit Sugunan Shinto
Journal:  World J Nucl Med       Date:  2015 Sep-Dec

8.  188Re radiopharmaceuticals for radiosynovectomy: evaluation and comparison of tin colloid, hydroxyapatite and tin-ferric hydroxide macroaggregates.

Authors:  Eduardo Savio; María Cristina Ures; Patricia Zeledón; Victoria Trindade; Andrea Paolino; Virginia Mockford; Antonio Malanga; Marcelo Fernández; Javier Gaudiano
Journal:  BMC Nucl Med       Date:  2004-01-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.